BNP PARIBAS ASSET MANAGEMENT Holding S.A. Purchases 13,618 Shares of HCA Healthcare, Inc. (NYSE:HCA)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 12.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 120,149 shares of the company’s stock after buying an additional 13,618 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A.’s holdings in HCA Healthcare were worth $48,832,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Acadian Asset Management LLC lifted its stake in HCA Healthcare by 115.5% in the 1st quarter. Acadian Asset Management LLC now owns 3,372 shares of the company’s stock worth $1,123,000 after purchasing an additional 1,807 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after acquiring an additional 2,584 shares during the last quarter. CreativeOne Wealth LLC bought a new position in shares of HCA Healthcare in the first quarter worth approximately $231,000. Advisors Asset Management Inc. lifted its position in HCA Healthcare by 117.5% during the first quarter. Advisors Asset Management Inc. now owns 2,543 shares of the company’s stock valued at $848,000 after purchasing an additional 1,374 shares during the last quarter. Finally, 1832 Asset Management L.P. bought a new position in shares of HCA Healthcare in the 1st quarter worth $26,672,000. 62.73% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on HCA shares. Morgan Stanley began coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. UBS Group upped their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, TD Cowen decreased their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $385.00.

Insider Activity at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock worth $5,608,990 over the last ninety days. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Trading Down 0.2 %

NYSE:HCA opened at $332.22 on Friday. HCA Healthcare, Inc. has a 12 month low of $245.84 and a 12 month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company has a 50-day moving average price of $380.80 and a 200-day moving average price of $357.94. The stock has a market cap of $84.15 billion, a price-to-earnings ratio of 14.92, a P/E/G ratio of 1.29 and a beta of 1.68.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.